# SILODOSIN
> **ANDA211731** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2019-11-22
## Drug
- **FDA Application Number:** ANDA211731
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILODOSIN
- **Generic name:** SILODOSIN
- **Active ingredients:** SILODOSIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2019-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211731)
---
*MORVS · CC0 1.0*